FG, No argument here! Same page, eye to eye, wh
Post# of 30028
(Total Views: 584)
Posted On: 09/05/2020 3:02:13 AM
FG,
No argument here!
Same page, eye to eye, whatever you wanna call it.
That's all from Todos COVID-19 game plan alone.
Once news starts rolling out on all that Todos has going on non-covid it will be nitro!
I have a feeling just from what Gerald has been saying that LymPro IUO could be announced "soon".
Could that be 1 pharma company or more? No clue, but now that they speak in definitive tears that ALZ is a "form" of cancer, there could be a few Pharma companies lined up to take a shot.
Since AMBS now gets 10% of what Todos makes off of LymPro that will propel us pretty quickly.
That's revenue not a percentage of shares.
Hempori and last we heard about it, it sounded real promising.
Elto Pharma up for grabs. And to watch what CURE has been doing it nearly is the blueprint of what AMBS & EMOR could do.
Not sure what kinda piece we can or will get from Theralink, but there could be yet, another small revenue stream. And another possible CLIA Lab, but I am not sure if there is an open door for that.
As for EMOR/ CARIE, I am really really intrigued of what is being put together and how AMBs could pull in cash.
Much of this will unfold (MANF humor) by the end of the year, though we could be looking at your high number as our low number within months (or weeks) if the COVID Antigen Test Killer (CATK) comes in with solid numbers.
If that is the case, then that alone will bring in mountains of cash worldwide!
It sounds like there are buyers lined up once there's a go ahead.
All of this is conditional of course.
What I have seen from Gerald is , this year there is zero hype. Some excitement sure, but he only speaks of things that are pretty much set up already.
Far different situation we're in now.
And I'm sure Gerald has his sites on another asset, but won't jeopardize AMBS to purchase anything this time.
Just what I see.
We'll see soon enough.
Aloha
No argument here!
Same page, eye to eye, whatever you wanna call it.
That's all from Todos COVID-19 game plan alone.
Once news starts rolling out on all that Todos has going on non-covid it will be nitro!
I have a feeling just from what Gerald has been saying that LymPro IUO could be announced "soon".
Could that be 1 pharma company or more? No clue, but now that they speak in definitive tears that ALZ is a "form" of cancer, there could be a few Pharma companies lined up to take a shot.
Since AMBS now gets 10% of what Todos makes off of LymPro that will propel us pretty quickly.
That's revenue not a percentage of shares.
Hempori and last we heard about it, it sounded real promising.
Elto Pharma up for grabs. And to watch what CURE has been doing it nearly is the blueprint of what AMBS & EMOR could do.
Not sure what kinda piece we can or will get from Theralink, but there could be yet, another small revenue stream. And another possible CLIA Lab, but I am not sure if there is an open door for that.
As for EMOR/ CARIE, I am really really intrigued of what is being put together and how AMBs could pull in cash.
Much of this will unfold (MANF humor) by the end of the year, though we could be looking at your high number as our low number within months (or weeks) if the COVID Antigen Test Killer (CATK) comes in with solid numbers.
If that is the case, then that alone will bring in mountains of cash worldwide!
It sounds like there are buyers lined up once there's a go ahead.
All of this is conditional of course.
What I have seen from Gerald is , this year there is zero hype. Some excitement sure, but he only speaks of things that are pretty much set up already.
Far different situation we're in now.
And I'm sure Gerald has his sites on another asset, but won't jeopardize AMBS to purchase anything this time.
Just what I see.
We'll see soon enough.
Aloha
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼